Send us Feedback

Cardiome Pharma (CRME)
Analysis
SUMMARY
BULLS
BEARS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Cardiome Reports First Quarter Results
Globe Newswire  May 11  Comment 
VANCOUVER, British Columbia, May 11, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) today reported financial results for the first quarter ended March 31, 2012. Amounts, unless specified otherwise, are expressed in U.S.
Cardiome to Release First Quarter 2012 Financial Results
Globe Newswire  May 10  Comment 
VANCOUVER, British Columbia, May 10, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) today announced that it will report financial results for the first quarter ended March 31, 2012 on the afternoon of Friday, May 11, 2012.
Cardiome Receives Notification From NASDAQ
Globe Newswire  May 4  Comment 
VANCOUVER, British Columbia, May 4, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) ("the Company") today announced that it received written notification from The NASDAQ Stock Market ("NASDAQ") on May 1, 2012 advising the
Cardiome to Release Fourth Quarter and Fiscal 2011 Results
Globe Newswire  Mar 27  Comment 
VANCOUVER, British Columbia, March 27, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) today announced that it will report financial results for the fourth quarter and fiscal year ended December 31, 2011 on the afternoon of
Notable 52-Week Highs and Lows of the Day 03/21: (GALE) (USG) (LGF) (FSII) High; (VALV) (CRME) Low
StreetInsider.com  Mar 21  Comment 
This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today. 52-Week High: Galena Biopharma (Nasdaq: GALE) high of $2.93. After a 25.8 percent move higher Tuesday, Galena is up another 50...
Oppenheimer Downgrades Cardiome Pharmaoration from Outperform to Perform, Removes PT
Benzinga  Mar 19  Comment 
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
Unusual 11 Mid-Day Movers 03/19: (AMPE) (KNSY) (FRO) Higher; (CRME) (COGO) (MEMS) Lower
StreetInsider.com  Mar 19  Comment 
Cardiome Pharma Corp. (Nasdaq: CRME) 53.9% LOWER; today announced that Merck (NYSE: MRK) has communicated to Cardiome their decision to discontinue further development of the oral formulation of vernakalant. The decision was based on Merck's...
Morning Movers 03/19: (AMPE) (ABVT) (IPSU) Higher; (CRME) Lower
StreetInsider.com  Mar 19  Comment 
Morning Market Losers
Benzinga  Mar 19  Comment 
Cardiome Pharma Corporation (NASDAQ: CRME) shares dipped 44.04% to $1.08 at 9:54 am. CRME reported that Merck has communicated to Cardiome their decision to discontinue further development of the Vernakalant Oral. WPCS International...
Cardiome whips out budget ax as Merck dumps oral heart drug pact
FierceBiotech  Mar 19  Comment 
Cardiome's long-running roller coaster ride with its atrial fibrillation drug vernakalant went into a steep descent this morning when the biotech announced that Merck ($MRK) is dumping its involvement in the oral formulation of the therapy. Shares...
Merck (MRK) to Discontinue Further Development of Cardiome's (CRME) Vernakalant
StreetInsider.com  Mar 19  Comment 
Cardiome Provides Update on Merck's Development Plans for Vernakalant Oral
Benzinga  Mar 19  Comment 
Cardiome plunges on cardiac drug setback
MarketWatch  Mar 19  Comment 
Unusual 11 Midday Movers 12/29: (HOLI) (CRME) (IVAN) (AAU) Higher; (BLDP) (OPXT) (DECK) Lower
StreetInsider.com  Dec 29  Comment 
Hollysys Automation Technologies (NASDAQ: HOLI) 15.5% HIGHER; Roth Capital today upgraded the company to a Buy rating and raised its price target on the stock from $9.50 to $10. Cardiome Pharma (Nasdaq: CRME) 13.3% HIGHER; after testing and...
Morning Movers 12/29: (DEXO) (CRME) Higher; (DECK) (AMZN) Lower
StreetInsider.com  Dec 29  Comment 
Morning Market Movers
Benzinga  Dec 29  Comment 




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/Cardiome_Pharma_(CRME)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki